Top Industry Leaders in the Anophthalmia and Microphthalmia Market
Latest Anophthalmia and Microphthalmia Companies Updates:
Santen Pharmaceutical Developing gene therapy for Leber's congenital amaurosis, a rare eye disease with potential applications for other eye conditions.
Alnylam Pharmaceuticals Leading the way in RNA interference technology, which has potential for treating genetic diseases affecting the eyes.
Bausch + Lomb A major player in ophthalmic devices, including prosthetics and implants, relevant to Anophthalmia and Microphthalmia patients.
List of Anophthalmia and Microphthalmia Key companies in the market:
- Bristol-Myers Squibb Company
- NUSAPURE
- ALLERGAN
- Aerie Pharmaceuticals, Inc.
- Pfizer Inc.
- Valeant Pharmaceuticals International, Inc.
- Bayer AG
- Genentech, Inc.
- Novartis AG
- Regeneron Pharmaceuticals, Inc.
- Shire,
- Santen Pharmaceutical Co., Ltd.
